BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26150022)

  • 1. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
    Gardner JC; Courter JD; Dandoy CE; Davies SM; Teusink-Cross A
    Transplant Cell Ther; 2022 Mar; 28(3):167.e1-167.e5. PubMed ID: 34875405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
    Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
    Kim JH; Goulston C; Zangari M; Tricot G; Boyer MW; Hanson KE
    Transpl Infect Dis; 2014 Jun; 16(3):421-9. PubMed ID: 24797543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
    Maakaron JE; Liscynesky C; Boghdadly ZE; Huang Y; Agyeman A; Brammer J; Penza S; Efebera Y; Benson D; Rosko A; William B; Jaglowski SM
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):e198-e201. PubMed ID: 32304873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
    Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.
    Hafez HA; Yousif D; Abbassi M; Elborai Y; Elhaddad A
    Clin Transplant; 2015 Dec; 29(12):1112-8. PubMed ID: 26363413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
    Satlin MJ; Chavda KD; Baker TM; Chen L; Shashkina E; Soave R; Small CB; Jacobs SE; Shore TB; van Besien K; Westblade LF; Schuetz AN; Fowler VG; Jenkins SG; Walsh TJ; Kreiswirth BN
    Clin Infect Dis; 2018 Nov; 67(11):1720-1728. PubMed ID: 29701766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
    Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
    Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation.
    Wang X; Ren J; Liang X; He P
    Hematology; 2021 Dec; 26(1):950-955. PubMed ID: 34904529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
    Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
    Copeland V; McLaughlin M; Trifilio S
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation.
    Mürner CM; Stenner-Liewen F; Seifert B; Mueller NJ; Schmidt A; Renner C; Schanz U; Knuth A; Manz MG; Scharl M; Gerber B; Samaras P
    Leuk Lymphoma; 2019 Mar; 60(3):685-695. PubMed ID: 30126310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients.
    Guimarães T; Borges IC; Spadão FS; Mariano L; Nascimento MM; Higashino H; Rossi F; Rocha V; Costa SF
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36140048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
    Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
    Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.